Aeglea Biotherapeutics Inc. – Investors and Politicians Who Own It
SYRE, 2 share classes and securities
Investors who own it
3 tracked investors, $786.2M in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
Joseph EdelmanPerceptive Advisors, Q2 2026 | $383.5M | 5.76% |
Rod WongRTW Investments, Q2 2026 | $377.5M | 3.22% |
Daniel SchneebergerADAR1 Capital Management, Q2 2026 | $25.2M | 1.15% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| Joseph Edelman | Reduced −10% | 2,574,723 |
| David Kroin | Reduced −78% | 219,015 |
| Behzad Aghazadeh | Sold out | 0 |
| Rod Wong | Added +11% | 3,621,996 |
| George Soros | Added +72% | 250,000 |
| Daniel Schneeberger | Sold out | 0 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
No disclosed Congress trades in this stock.